METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer
Clinical trial NCT06884345 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06884345
- Sponsor
- Anhui Provincial Cancer Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-13
- Primary completion
- 2026-12-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.